Abstract
Upon activation, mast cells release many mediators, including reactive oxygen species (ROS) and tumor necrosis factor (TNF) orchestrating allergic inflammation. Nanocarriers (NCs) that can detect mast cell activation and respond by releasing anti-inflammatory compounds in real-time, would and effective therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
